Maximum organ toxicities
. | Organ toxicities, no. patients (%) . | . | . | . | . | . | . | . | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Grade . | Renal . | Hepatic . | Pulmonary . | Cardiac . | GI . | Mucositis . | CNS . | Infection . | |||||||
| 0 | 42 (59) | 34 (48) | 51 (72) | 54 (76) | 32 (45) | 10 (14) | 57 (80) | 19 (27) | |||||||
| I | 11 (15) | 1 (1) | 6 (8) | 2 (3) | 15 (21) | 8 (11) | 4 (6) | 0 (0) | |||||||
| II | 10 (14) | 10 (14) | 2 (3) | 4 (6) | 16 (23) | 16 (23) | 6 (8) | 3 (4) | |||||||
| III | 4 (6) | 16 (23) | 8 (11) | 8 (11) | 7 (10) | 37 (52) | 4 (6) | 42 (59) | |||||||
| IV | 4 (6) | 10 (14)* | 4 (6) | 3 (4) | 1 (1) | 0 (0) | 0 (0) | 7 (10) | |||||||
. | Organ toxicities, no. patients (%) . | . | . | . | . | . | . | . | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Grade . | Renal . | Hepatic . | Pulmonary . | Cardiac . | GI . | Mucositis . | CNS . | Infection . | |||||||
| 0 | 42 (59) | 34 (48) | 51 (72) | 54 (76) | 32 (45) | 10 (14) | 57 (80) | 19 (27) | |||||||
| I | 11 (15) | 1 (1) | 6 (8) | 2 (3) | 15 (21) | 8 (11) | 4 (6) | 0 (0) | |||||||
| II | 10 (14) | 10 (14) | 2 (3) | 4 (6) | 16 (23) | 16 (23) | 6 (8) | 3 (4) | |||||||
| III | 4 (6) | 16 (23) | 8 (11) | 8 (11) | 7 (10) | 37 (52) | 4 (6) | 42 (59) | |||||||
| IV | 4 (6) | 10 (14)* | 4 (6) | 3 (4) | 1 (1) | 0 (0) | 0 (0) | 7 (10) | |||||||
Toxicity grading according to NCI common toxicity criteria (CTC 2.0) with recommended adaptations for bone marrow transplantation.
Includes 2 suspected severe veno-occlusive diseases